Business ❯ Corporate Governance ❯ Leadership Changes ❯ Executive Appointments

Ester Banque

FDA Panel Weighs Moderna’s Bid for First U.S. mRNA Flu Vaccine

A favorable advisory vote could clear a faster, reformulatable mRNA platform for U.S. use while requiring confirmatory studies to address gaps for older adults.